Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

141.05
-1.5200-1.07%
Post-market: 141.050.00000.00%19:30 EDT
Volume:2.06M
Turnover:291.05M
Market Cap:269.12B
PE:21.32
High:142.50
Open:142.22
Low:140.87
Close:142.57
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:1.06
T/O Rate:0.11%
Dividend:4.67
Dividend Rate:3.31%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.48
PE(LYR):19.73

Loading ...

Novartis' Vanrafia Wins Health Canada Approval for IgA Nephropathy

MT Newswires Live
·
Jul 14

Novartis AG Rises Monday

Dow Jones
·
Jul 14

Can AI Make Better Drugs? not on Wall Street's Timeline

Dow Jones
·
Jul 12

Movement Alert|Novartis Falls 4.48% in After-Hours Trading, China Procurement Forgery Scandal and Aggressive M&A Spree Weigh on Shares

Market Focus
·
Jul 08

Dow Jones Top Company Headlines at 1 PM ET: Lockheed Martin to Acquire Ultra Maritime in $3.45 Billion Deal | Microsoft ...

Dow Jones
·
Jul 07

Movement Alert|Novartis Falls 3.05% in Regular Trading, $1.5 Billion Myricx Bio Acquisition Triggers Selling Pressure

Market Focus
·
Jul 06

Sector Update: Healthcare

MT Newswires Live
·
Jul 06

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday as Chip Stocks Rebound

MT Newswires Live
·
Jul 06

Dow Jones Top Company Headlines at 7 am ET: Michael Saylor's Strategy is Trapped by Its Own Broken Bitcoin Math | Easyjet ...

Dow Jones
·
Jul 06

Novartis agrees to acquire Myricx Bio for up to $1.5B

TIPRANKS
·
Jul 06

Novartis Bolsters Oncology Pipeline with $1.5 Billion Acquisition of Myricx Bio

Stock News
·
Jul 06

Novartis's Myricx Bio Upfront Payment Looks High

Dow Jones
·
Jul 06

Movement Alert|Novartis Rises 3.01% in Regular Trading, Spinal Muscular Atrophy Gene Therapy Wins EU Approval

Market Focus
·
Jul 02

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday Amid Latest Economic Reports

MT Newswires Live
·
Jul 02

Novartis Wins European Approval For Spinal Muscular Atrophy Gene Therapy

MT Newswires Live
·
Jul 02

Novartis, Antares Therapeutics Sign Oncology Drug Discovery Deal Worth Up to $1.9 Billion

MT Newswires Live
·
Jun 24

Movement Alert|Novartis Rises 3.01% in Regular Trading, Antibody-Conjugated Oligonucleotide Drug Delivers Positive Early Clinical Data

Market Focus
·
Jun 24

Switzerland Voted Against a Population Cap but This Isn't the Last We'll Hear About It -- Barrons.com

Dow Jones
·
Jun 19

Novartis' Rhapsido Meets Primary Endpoints in Chronic Inducible Urticaria Trial

MT Newswires Live
·
Jun 12

Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), Insulet (PODD) and Novartis (NVS)

TIPRANKS
·
Jun 12